| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/05/2011 | US20110107450 Soybean Cultivar S080193 |
| 05/05/2011 | US20110107449 Soybean Cultivar S080190 |
| 05/05/2011 | US20110107448 Soybean Cultivar S080191 |
| 05/05/2011 | US20110107447 Soybean Cultivar S080192 |
| 05/05/2011 | US20110107446 Methods and compositions for plant pest control |
| 05/05/2011 | US20110107445 Efficient Insertion of DNA Into Embryonic Stem Cells |
| 05/05/2011 | US20110107444 Novel poly(adp-ribose) polymerase genes |
| 05/05/2011 | US20110107443 Novel protein transduction domains derived from secretory leukocyte protease inhibitor |
| 05/05/2011 | US20110107441 Animals with reduced body fat and increased bone density |
| 05/05/2011 | US20110105998 Systems, methods and compositions for optical stimulation of target cells |
| 05/05/2011 | US20110105741 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction |
| 05/05/2011 | US20110105740 Soluble tnf receptors and their use in treatment of disease |
| 05/05/2011 | US20110105735 Methods of producing and purifying proteins |
| 05/05/2011 | US20110105731 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 05/05/2011 | US20110105724 Novel compounds |
| 05/05/2011 | US20110105721 Peptides |
| 05/05/2011 | US20110105718 Nel-related protein type 1 antibody |
| 05/05/2011 | US20110105595 Novel promoter and viral vector containing the same |
| 05/05/2011 | US20110105593 MicroRNA-Formatted Multitarget Interfering RNA Vector Constructs and Methods of Using The Same |
| 05/05/2011 | US20110105592 Anti-sense microrna expression vectors |
| 05/05/2011 | US20110105590 Compositions And Methods For Inhibiting Expression Of Anti-Apoptotic Genes |
| 05/05/2011 | US20110105589 Apoptosis inducer |
| 05/05/2011 | US20110105588 Compositions comprising notch1 sirna and methods of use thereof |
| 05/05/2011 | US20110105587 Target sequences and methods to identify the same, useful in treatment of neurodegenerative diseases |
| 05/05/2011 | US20110105582 Composition for inhibiting function of human flt3 |
| 05/05/2011 | US20110105422 Use of g-rich oligonucleotides for treating neoplastic diseases |
| 05/05/2011 | US20110105416 Novel Antimicrobial Peptides |
| 05/05/2011 | US20110105411 Disease-Associated Proteins |
| 05/05/2011 | US20110105407 Tissue Inhibitor of Metalloproteinases (Timp) Linked to Glycosylphosphatidylinositol (Gpi) - Anchors for Treatment of Cancer and Skin Lesions |
| 05/05/2011 | US20110105376 Enhanced Amylase Production by N-Terminal Addition to Mature Amylase Protein |
| 05/05/2011 | US20110105354 Methods and Apparatus for Conducting Multiple Measurements on a Sample |
| 05/05/2011 | US20110104806 Regulating the production of long chain hydrocarbons |
| 05/05/2011 | US20110104805 Pluripotent Stem Cells |
| 05/05/2011 | US20110104799 Multifunctional Alleles |
| 05/05/2011 | US20110104789 Non-integrating rev-dependent lentiviral vector and methods of using the same |
| 05/05/2011 | US20110104788 Modulation of Adenoviral Tropism |
| 05/05/2011 | US20110104787 Fusion Peptides That Bind to and Modify Target Nucleic Acid Sequences |
| 05/05/2011 | US20110104779 Heat-stable carbonic anhydrases and their use |
| 05/05/2011 | US20110104761 Thermostable dna polymerase from palaeococcus helgesonii |
| 05/05/2011 | US20110104758 Recombinant cell clones having increased stability and methods of making and using the same |
| 05/05/2011 | US20110104757 Human anti-B7RP1 Neutralizing Antibodies |
| 05/05/2011 | US20110104756 HUMAN IgM ANTIBODIES, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF PARTICULARLY IN THE CENTRAL NERVOUS SYSTEM |
| 05/05/2011 | US20110104753 Soluble Recombinant Influenza Antigens |
| 05/05/2011 | US20110104752 Variation of Recombinant Expression Titres By Optimising Bacterial Ribosome Binding Sites |
| 05/05/2011 | US20110104751 Variant form of urate oxidase and use thereof |
| 05/05/2011 | US20110104750 Filamentous Fungi Having Reduced UDP-Galactofuranose Content |
| 05/05/2011 | US20110104749 Modified yeasts and uses thereof, in particular for producing steroid derivatives |
| 05/05/2011 | US20110104745 Method of expressing recombinant protein in cho cells |
| 05/05/2011 | US20110104740 Fluorescent protein and chromoprotein |
| 05/05/2011 | US20110104734 Novel strategy to reduce lactic acid production and control ph in animal cell culture |
| 05/05/2011 | US20110104728 Biliverdin from a Non-Animal Source |
| 05/05/2011 | US20110104713 Products and processes for modulating peptide-peptide binding domain interactions |
| 05/05/2011 | US20110104710 Construction of expression system for rna polymerase derived from influenza virus, crystallization of the rna polymerase, and screening method for anti-influenza agent |
| 05/05/2011 | US20110104706 Novel kinases and uses thereof |
| 05/05/2011 | US20110104691 Androgenetic alopecia |
| 05/05/2011 | US20110104682 Rna detection assays |
| 05/05/2011 | US20110104681 Novel transgene assay using stable agrobacterium rhizogenes transformation |
| 05/05/2011 | US20110104678 Polymerase inhibitor and method of using same |
| 05/05/2011 | US20110104675 Methods and Compositions for Diagnosing Carcinomas |
| 05/05/2011 | US20110104668 Nucleic acid ligands against infectious prions |
| 05/05/2011 | US20110104665 Mutant sodium channel nav 1.7 and methods related thereto |
| 05/05/2011 | US20110104360 Lignan hydroxylase |
| 05/05/2011 | US20110104331 Glucose-induced inactivation/degradation-resistant transporter gene and use thereof |
| 05/05/2011 | US20110104226 Peptides having binding affinity to an antibody which recognizes an epitope on an a1 loop 2 or beta2 loop 1 of an adrenoreceptor |
| 05/05/2011 | US20110104209 Dna sequence, and recombinant preparation of the grass pollen allergen lol p4 |
| 05/05/2011 | US20110104201 Porcine Reproductive and Respiratory Syndrome Vaccine Based on Isolate JA-142 |
| 05/05/2011 | US20110104199 MVA Expressing Modified HIV Envelope, GAG, and POL Genes |
| 05/05/2011 | US20110104193 Combination neisserial compositions |
| 05/05/2011 | US20110104176 Antibody specifically binding to c-met and use thereof |
| 05/05/2011 | US20110104169 Regulator genes of angiogenesis, pharmaceutical preparations containing them and their applications |
| 05/05/2011 | US20110104152 Chimeric fibroblast growth factors with altered receptor specificity |
| 05/05/2011 | US20110104148 Antibodies to Carcinoembryonic Antigen (CEA), Methods of Making Same, and Uses Thereof |
| 05/05/2011 | US20110104133 Methods and compositions for inducing brown adipogenesis |
| 05/05/2011 | US20110104131 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 05/05/2011 | US20110104130 Thymidylate kinase fusions and uses thereof |
| 05/05/2011 | US20110104129 T cell receptors and related materials and methods of use |
| 05/05/2011 | US20110104120 Directed Evolution and In Vivo Panning of Virus Vectors |
| 05/05/2011 | US20110104118 Compositions and methods for therapeutic use |
| 05/05/2011 | US20110104117 Metabolically activated recombinant viral vectors and methods for their preparation and use |
| 05/05/2011 | US20110104112 Targeted interferons demonstrate potent apoptotic and anti-tumor activities |
| 05/05/2011 | US20110104059 Membrane Associated Tumor Endothelium Markers |
| 05/05/2011 | US20110104050 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin |
| 05/05/2011 | US20110100263 Hot Spring Bacterial Strain BKH1 and Protein Isolated Therefrom, Concrete Compositions, and Uses Thereof |
| 05/05/2011 | US20110099892 Microorganism expressing aldose-1-epimerase |
| 05/05/2011 | DE112008003316T5 Pflanzen mit gesteigerten ertragsbezogenen Eigenschaften und Verfahren zur Herstellung derselben Plants having enhanced yield-related traits and methods of making the same |
| 05/05/2011 | DE10311106B4 Peptide gegen Kälteunverträglichkeit hervorrufende Autoantikörper, dafür kodierende Nukleinsäuren, ihre Verwendung und diese umfassende pharmazeutische Zusammensetzungen Peptides against cold intolerance inducing autoantibodies, nucleic acids encoding, their use and pharmaceutical compositions comprising |
| 05/05/2011 | DE102009050308A1 New polyribonucleotide, having protein encoding sequence that comprises combination of unmodified and modified nucleotides and is obtained from mixture of ATP, guanosine-, cytidine- and uridine-triphosphate, useful e.g. for coating implant |
| 05/05/2011 | CA2779615A1 Therapeutic nuclease compositions and methods |
| 05/05/2011 | CA2779512A1 Vault complexes for cytokine delivery |
| 05/05/2011 | CA2779495A1 Encoding text into nucleic acid sequences |
| 05/05/2011 | CA2779387A1 Gene capable of imparting environmental stress resistance to plants and method for utilizing the same |
| 05/05/2011 | CA2779337A1 Homologous recombination in the oocyte |
| 05/05/2011 | CA2779310A1 Methods for reprogramming cells and uses thereof |
| 05/05/2011 | CA2779273A1 Enhanced gene expression in algae |
| 05/05/2011 | CA2779039A1 Generating induced pluripotent stem cells and progenitor cells from fibroblasts |
| 05/05/2011 | CA2778945A1 Cardiac-specific nucleic acid regulatory elements and methods and use thereof |
| 05/05/2011 | CA2778895A1 Compositions and methods for treating inflammatory disorders |
| 05/05/2011 | CA2778893A1 Dna vaccine against the yellow fever virus |
| 05/05/2011 | CA2778759A1 Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood |
| 05/05/2011 | CA2778668A1 Cloning, expression and use of acid phospholipases |